DE-310, a macromolecular prodrug of the topoisomerase-I-inhibitor exatecan (DX-8951), in patients with operable solid tumors

Author: Wente Moritz   Kleeff Jörg   Büchler Markus   Wanders Jantien   Cheverton Peter   Langman Stephen   Friess Helmut  

Publisher: Springer Publishing Company

ISSN: 0167-6997

Source: Investigational New Drugs, Vol.23, Iss.4, 2005-08, pp. : 339-347

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content